Annual Retained Earnings
-$131.01 M
-$14.80 M-12.74%
December 31, 2023
Summary
- As of February 10, 2025, AGE annual retained earnings is -$131.01 million, with the most recent change of -$14.80 million (-12.74%) on December 31, 2023.
- During the last 3 years, AGE annual retained earnings has fallen by -$33.94 million (-34.96%).
Performance
AGE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$131.01 M
-$3.46 M-2.71%
December 31, 2023
Summary
- As of February 10, 2025, AGE quarterly retained earnings is -$131.01 million, with the most recent change of -$3.46 million (-2.71%) on December 31, 2023.
- Over the past year, AGE quarterly retained earnings has dropped by -$14.80 million (-12.74%).
Performance
AGE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AGE Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -12.7% | -12.7% |
3 y3 years | -35.0% | -35.0% |
5 y5 years | -76.9% | -76.9% |
AGE Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | +23.9% | at low | +23.9% | at low |
5 y | 5-year | +52.0% | at low | +52.0% | at low |
alltime | all time | +96.9% | at low | +76.9% | at low |
AgeX Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | -$131.01 M(+12.7%) | -$131.01 M(+2.7%) |
Sep 2023 | - | -$127.56 M(+4.4%) |
Jun 2023 | - | -$122.16 M(+2.2%) |
Mar 2023 | - | -$119.49 M(+2.8%) |
Dec 2022 | -$116.21 M(+9.9%) | -$116.21 M(+2.4%) |
Sep 2022 | - | -$113.51 M(+2.2%) |
Jun 2022 | - | -$111.07 M(+2.4%) |
Mar 2022 | - | -$108.45 M(+2.6%) |
Dec 2021 | -$105.75 M | -$105.75 M(+2.1%) |
Sep 2021 | - | -$103.59 M(+1.9%) |
Jun 2021 | - | -$101.64 M(+2.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | -$99.16 M(+2.2%) |
Dec 2020 | -$97.07 M(+12.6%) | -$97.07 M(+2.6%) |
Sep 2020 | - | -$94.63 M(+2.8%) |
Jun 2020 | - | -$92.08 M(+3.0%) |
Mar 2020 | - | -$89.39 M(+3.7%) |
Dec 2019 | -$86.21 M(+16.4%) | -$86.21 M(+3.2%) |
Sep 2019 | - | -$83.50 M(+4.0%) |
Jun 2019 | - | -$80.28 M(+4.0%) |
Mar 2019 | - | -$77.19 M(+4.2%) |
Dec 2018 | -$74.05 M(+11.3%) | -$74.05 M |
Dec 2017 | -$66.55 M | - |
FAQ
- What is AgeX Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for AgeX Therapeutics?
- What is AgeX Therapeutics annual retained earnings year-on-year change?
- What is AgeX Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for AgeX Therapeutics?
- What is AgeX Therapeutics quarterly retained earnings year-on-year change?
What is AgeX Therapeutics annual retained earnings?
The current annual retained earnings of AGE is -$131.01 M
What is the all time high annual retained earnings for AgeX Therapeutics?
AgeX Therapeutics all-time high annual retained earnings is -$66.55 M
What is AgeX Therapeutics annual retained earnings year-on-year change?
Over the past year, AGE annual retained earnings has changed by -$14.80 M (-12.74%)
What is AgeX Therapeutics quarterly retained earnings?
The current quarterly retained earnings of AGE is -$131.01 M
What is the all time high quarterly retained earnings for AgeX Therapeutics?
AgeX Therapeutics all-time high quarterly retained earnings is -$74.05 M
What is AgeX Therapeutics quarterly retained earnings year-on-year change?
Over the past year, AGE quarterly retained earnings has changed by -$14.80 M (-12.74%)